Sleep News and Research

Latest Sleep News and Research

Learning new tasks causes changes in spontaneous brain activity patterns: Study

Spontaneous brain activity formerly thought to be "white noise" measurably changes after a person learns a new task, researchers at Washington University School of Medicine in St. Louis and the University of Chieti, Italy, have shown.

9 Oct 2009

Uvopalatopharyngoplasty surgery is effective for treating sleep apnea disorder

According to research recently published by an Oregon Health & Science University scientist, a form of surgery called uvopalatopharyngoplasty is effective for treating certain patients who suffer from sleep apnea, one of the most common sleep disorders.

9 Oct 2009

New soy germ-based ingredient improves menopausal symptoms

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

9 Oct 2009

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

With advancements in the field of stem cell research accelerating, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) will hold its third Symposium on Cardiovascular Regenerative Medicine to review the latest findings in the field and examine future directions.

9 Oct 2009

Study raises concerns on long-term consequences of neonatal caffeine administration on brain development

An F1000 evaluation looks at a Canadian study on how giving caffeine to newborn rats has a long-lasting and detrimental effect on sleep and breathing in adulthood

9 Oct 2009

Overweight individuals at greater risk of having SDB

Overweight individuals are not just at greater risk of having sleep-disordered-breathing (SDB), they are also likely to suffer greater consequences, according to new research.

8 Oct 2009

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

7 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

Working Nights Spanish Calendar for Hispanics to improve their security and wellbeing

Circadian Age, Inc. – ‘Working Nights’ – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is announcing a new Spanish calendar. The 2010 Working Nights Spanish Calendar offers organizations with Hispanic workers the opportunity to show added concern about the health and safety of this group of employees, by providing them with educational material in their own language, to use at home.

7 Oct 2009

Brain injuries in Ontario's construction industry are highest in August and October

August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.

7 Oct 2009

Presbyterian Hospital implements Defensive Monitoring solution for their post-surgical patients

Presbyterian Hospital will “go live” today with a Defensive Monitoring™ solution for their post-surgical patients: A Prefense™ Early Detection and Notification™ System from Nihon Kohden America, Inc.

7 Oct 2009

Parents should watch out for flu warning signs, says Minnesota physicians

Minnesota's physicians are urging parents to watch for the warning signs that their child is having a severe case of H1N1 and to seek out the H1N1 vaccine for their child when it becomes available.

7 Oct 2009

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Nearly all patients who underwent surgery to treat oropharyngeal cancer experienced some degree of obstructive sleep apnea (OSA), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

7 Oct 2009

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.

7 Oct 2009

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL (“Biovail”), a subsidiary of Biovail Corporation.

6 Oct 2009

Pepsico's initiative to reduce obesity, joins HWCF

PepsiCo, Inc., one of the world's largest food and beverage companies, today announced that it will expand its existing efforts to help reduce obesity in the United States by joining the Healthy Weight Commitment Foundation (HWCF).

6 Oct 2009

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.

6 Oct 2009

Hypertrophic Cardiomyopathy causes sudden cardiac death in children and young adults

Since Congress declared October “National Sudden Cardiac Arrest Awareness Month” one year ago, more than 250,000 Americans have suffered SCA. For too many, the underlying cause was Hypertrophic Cardiomyopathy (HCM), an inherited disease that affects one out of 500 Americans. What makes it all the more troubling is that early diagnosis of HCM through simple and inexpensive screening can reduce the risk of sudden cardiac death.

6 Oct 2009

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

ResMed announces acquisition of Laboratoires Narval

ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.

From ResMed Corp 6 Oct 2009

Sleep News and Research

Latest Sleep News and Research

Learning new tasks causes changes in spontaneous brain activity patterns: Study

Uvopalatopharyngoplasty surgery is effective for treating sleep apnea disorder

New soy germ-based ingredient improves menopausal symptoms

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

Study raises concerns on long-term consequences of neonatal caffeine administration on brain development

Overweight individuals at greater risk of having SDB

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Working Nights Spanish Calendar for Hispanics to improve their security and wellbeing

Brain injuries in Ontario's construction industry are highest in August and October

Presbyterian Hospital implements Defensive Monitoring solution for their post-surgical patients

Parents should watch out for flu warning signs, says Minnesota physicians

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

Pepsico's initiative to reduce obesity, joins HWCF

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

Hypertrophic Cardiomyopathy causes sudden cardiac death in children and young adults

Depression leads to elevated inflammatory proteins in the human body: Study

ResMed announces acquisition of Laboratoires Narval

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sleep News and Research

Latest Sleep News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in